Using homeopathica drugs combination at peripartal phase in preventing bovine subclinical mastitis
DOI:
https://doi.org/10.13181/mji.v13i4.158Keywords:
Homeopathy, Homeopathic combination, Subclinical Mastitis, Peripartal PhaseAbstract
A total of 33 dairy lactating cows suffering from subclinical mastitis were classified into group A (10 cows), group B (12 cows) and group C (11 cows). They were treated with the combination of homeopathic drugs and placebo, applied at the 4th and 3rd week antepartum (a.p), and continuing every week postpartum (p.p), for four times. Group A received Coenzyme comp® (in the 4th and 3rd week a.p), Lachesis comp® combined with Traumeel®(1st and 2nd week p.p) and Coenzyme comp® combined with Carduus comp® (3rd and 4th week p.p). Group B received Traumeel®+ Mucosa comp® (4th and 3rd week a.p), Lachesis comp®+ Traumeel® (1st and 2nd week p.p) and Coenzyme comp®+ Carduus comp® (3rd and 4th week p.p) and group C as a placebo. The incidence of subclinical mastitis in group A and C appeared irregular. In contrast, group B showed a constant percentage (33.3%). Group A and B showed significant response to the homeopathic drugs, expressed as an increasing of the somatic cell count value. At peripartal phase, haptoglobin increased in group B 0.80 mg/ml and group A as well as placebo 1.40 mg/ml. After calving, group B expressed a constant value (0.05 mg/ml), while group A and placebo rose significantly. The milk yield in normal lactation period (the 3rd - 7th month) increased significantly, with an increasing 14.1% for group B and 4.9% A respectively. (Med J Indones 2004; 13: 221-6)
Downloads
Downloads
Published
How to Cite
Issue
Section
License
Authors who publish with Medical Journal of Indonesia agree to the following terms:
- Authors retain copyright and grant Medical Journal of Indonesia right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial License that allows others to remix, adapt, build upon the work non-commercially with an acknowledgment of the work’s authorship and initial publication in Medical Journal of Indonesia.
- Authors are permitted to copy and redistribute the journal's published version of the work non-commercially (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in Medical Journal of Indonesia.